Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15624037> ?p ?o }
Showing triples 1 to 40 of
40
with 100 triples per page.
- Q15624037 subject Q22902012.
- Q15624037 subject Q7336348.
- Q15624037 subject Q8501361.
- Q15624037 subject Q8522216.
- Q15624037 subject Q8546974.
- Q15624037 abstract "Macimorelin (INN) is a drug being developed by Æterna Zentaris for use in the diagnosis of adult growth hormone deficiency. As of January 2014, it is in Phase III clinical trials.Macimorelin is a mimic of ghrelin, a growth hormone secretagogue. It binds to the growth hormone secretagogue receptor (GHSR) causing release of growth hormone from the pituitary gland.".
- Q15624037 iupacName "2-Amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide".
- Q15624037 thumbnail Macimorelin.svg?width=300.
- Q15624037 wikiPageWikiLink Q14914301.
- Q15624037 wikiPageWikiLink Q20707542.
- Q15624037 wikiPageWikiLink Q20707829.
- Q15624037 wikiPageWikiLink Q21098924.
- Q15624037 wikiPageWikiLink Q21098925.
- Q15624037 wikiPageWikiLink Q21098927.
- Q15624037 wikiPageWikiLink Q21163357.
- Q15624037 wikiPageWikiLink Q2198549.
- Q15624037 wikiPageWikiLink Q22902012.
- Q15624037 wikiPageWikiLink Q3510429.
- Q15624037 wikiPageWikiLink Q369262.
- Q15624037 wikiPageWikiLink Q5036299.
- Q15624037 wikiPageWikiLink Q5611751.
- Q15624037 wikiPageWikiLink Q5984942.
- Q15624037 wikiPageWikiLink Q7180990.
- Q15624037 wikiPageWikiLink Q7336348.
- Q15624037 wikiPageWikiLink Q7391026.
- Q15624037 wikiPageWikiLink Q7673066.
- Q15624037 wikiPageWikiLink Q8077347.
- Q15624037 wikiPageWikiLink Q824258.
- Q15624037 wikiPageWikiLink Q8501361.
- Q15624037 wikiPageWikiLink Q8522216.
- Q15624037 wikiPageWikiLink Q8546974.
- Q15624037 iupacname "2".
- Q15624037 type ChemicalCompound.
- Q15624037 type ChemicalSubstance.
- Q15624037 type ChemicalObject.
- Q15624037 type Thing.
- Q15624037 type Q11173.
- Q15624037 comment "Macimorelin (INN) is a drug being developed by Æterna Zentaris for use in the diagnosis of adult growth hormone deficiency. As of January 2014, it is in Phase III clinical trials.Macimorelin is a mimic of ghrelin, a growth hormone secretagogue. It binds to the growth hormone secretagogue receptor (GHSR) causing release of growth hormone from the pituitary gland.".
- Q15624037 label "Macimorelin".
- Q15624037 depiction Macimorelin.svg.